| TKR | Tyrosine kinase receptor |
| SARS-CoV | Severe acute respiratory syndrome coronavirus |
| MERS-CoV | Middle East respiratory syndrome coronavirus |
| ACE2 | Angiotensin conversion enzyme 2 |
| RBD | Receptor-binding domain |
| HR | Heptane repeats |
| PRRs | Pattern recognition receptors |
| PAMP | Pathogen-associated molecular patterns |
| TLR | Toll-like receptor |
| RLR-RIG | I-like receptor |
| NLR-NOD | Like receptor |
| CLmin-C | Type lectin-like receptors |
| MDA5 | Cytosolic receptor melanoma differentiation-associated gene 5 |
| cGAS | Nucleotidyltransferase cyclic GMP-AMP synthase |
| NF-κB | Transcription factor nuclear factor-κB |
| IRF3 | Interferon regulatory factor 3 |
| IFN | Interferon |
| GFR | Growth factor receptors |
| EGFR | Epithelial growth factor receptor |
| NSCLC | Non-small-cell lung cancer |
| HMCV | Human cytomegalovirus |
| TKI | Tyrosine kinase inhibitors |
| PI3K | Phosphoinositide 3 kinase |
| TGEV | Transmissible gastroenteritis virus |
| FGFR | Fibroblast growth factor receptor |
| EBV | Epstein–Barr virus |
| NPC | Non-keratinizing nasopharyngeal cancer |
| PDGFR | Platelet-derived growth factor receptors |
| BTK | Bruton tyrosine kinase |
| SINE | Selective inhibitor of nuclear export |
| MHCV | Mouse hepatitis coronavirus |
| CEACAM1a | Carcinoembryonic antigen-related cell adhesion molecule 1 |
| JAKi | JAK inhibitors |
| BBB | Blood–brain barrier |